West Pharmaceutical Services Stock Today

WST Stock  USD 331.40  4.39  1.34%   

Performance

4 of 100

 
Weak
 
Strong
Insignificant

Odds Of Distress

Less than 1

 
High
 
Low
Very Small
West Pharmaceutical is selling for under 331.40 as of the 23rd of December 2024; that is 1.34 percent increase since the beginning of the trading day. The stock's last reported lowest price was 326.33. West Pharmaceutical has a very small chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Note, on December 9, 2024, Representative Jared Moskowitz of US Congress acquired under $15k worth of West Pharmaceutical's common stock.
Business Domain
Health Care Equipment & Services
IPO Date
13th of January 1978
Category
Healthcare
Classification
Health Care
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. West Pharmaceutical Services, Inc. The company has 72.42 M outstanding shares of which 1.16 M shares are at this time shorted by investors with about 1.86 days to cover. More on West Pharmaceutical Services

Moving together with West Stock

  0.72GH Guardant HealthPairCorr
  0.81LH LaboratoryPairCorr
  0.67MD Mednax IncPairCorr

Moving against West Stock

  0.68DRIO DarioHealth CorpPairCorr
  0.67EKSO Ekso Bionics HoldingsPairCorr
  0.57ELAB Elevai Labs, Common Buyout TrendPairCorr
  0.55CI Cigna CorpPairCorr
  0.55FIGS Figs IncPairCorr
  0.45VERO Venus ConceptPairCorr

West Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEOEric Green
Thematic Ideas
(View all Themes)
Old NameWistil S.A.
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, SP 500 Index, Obamacare Repeal, Rubber and Plastic Products, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.160.155
Sufficiently Up
Slightly volatile
Asset Turnover0.980.7703
Significantly Up
Pretty Stable
Gross Profit Margin0.260.3828
Way Down
Slightly volatile
Total Current Liabilities705.4 M671.8 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total307.8 M276.7 M
Moderately Up
Very volatile
Total AssetsB3.8 B
Sufficiently Up
Slightly volatile
Total Current AssetsB1.9 B
Sufficiently Up
Slightly volatile
Total Cash From Operating Activities815.3 M776.5 M
Sufficiently Up
Slightly volatile
Debt Levels
West Pharmaceutical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand West Pharmaceutical's financial leverage. It provides some insight into what part of West Pharmaceutical's total assets is financed by creditors.
Liquidity
West Pharmaceutical Services has 309 M in debt with debt to equity (D/E) ratio of 0.12, which may show that the company is not taking advantage of profits from borrowing. West Pharmaceutical has a current ratio of 3.72, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for West to invest in growth at high rates of return.

Depreciation

144.16 Million
West Pharmaceutical Services (WST) is traded on New York Stock Exchange in USA. It is located in 530 Herman O. West Drive, Exton, PA, United States, 19341-1147 and employs 10,600 people. West Pharmaceutical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 24 B. West Pharmaceutical runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 72.42 M outstanding shares of which 1.16 M shares are at this time shorted by investors with about 1.86 days to cover. West Pharmaceutical Services has about 894.3 M in cash with 776.5 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.85.
Check West Pharmaceutical Probability Of Bankruptcy
Ownership Allocation
West Pharmaceutical Services retains a total of 72.42 Million outstanding shares. The majority of West Pharmaceutical outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in West Pharmaceutical to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in West Pharmaceutical Services. Please pay attention to any change in the institutional holdings of West Pharmaceutical as this could imply that something significant has changed or is about to change at the company. Please note that on December 9, 2024, Representative Jared Moskowitz of US Congress acquired under $15k worth of West Pharmaceutical's common stock.
Check West Ownership Details

West Stock Institutional Holders

InstituionRecorded OnShares
Proshare Advisors Llc2024-09-30
1.1 M
Durable Capital Partners Lp2024-09-30
1.1 M
Morgan Stanley - Brokerage Accounts2024-09-30
971.5 K
Jpmorgan Chase & Co2024-09-30
968.4 K
Norges Bank2024-06-30
866.4 K
T. Rowe Price Investment Management,inc.2024-09-30
839.3 K
Findlay Park Partners Llp2024-09-30
827.7 K
Amvescap Plc.2024-09-30
747.4 K
Ubs Asset Mgmt Americas Inc2024-09-30
683.4 K
Vanguard Group Inc2024-09-30
M
Blackrock Inc2024-06-30
7.6 M
View West Pharmaceutical Diagnostics

West Pharmaceutical Historical Income Statement

At this time, West Pharmaceutical's Total Operating Expenses is comparatively stable compared to the past year. Income Before Tax is likely to gain to about 732.9 M in 2024, despite the fact that Non Operating Income Net Other is likely to grow to (27.9 M). View More Fundamentals

West Stock Against Markets

West Pharmaceutical Corporate Directors

Mark ButhmanIndependent DirectorProfile
Deborah TannerIndependent DirectorProfile
William FeeheryIndependent DirectorProfile
Robert FrielIndependent DirectorProfile

Already Invested in West Pharmaceutical Services?

The danger of trading West Pharmaceutical Services is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of West Pharmaceutical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than West Pharmaceutical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile West Pharmaceutical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

Additional Tools for West Stock Analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.